glp 1 receptor agonists for type 2 diabetes GLP-1 as Treatments GLP-1 receptor agonists are increasingly

Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality

Therefore, a lot of the time, a significant portion of the medication cost can be covered by insurance plans

Since GLP-1 patches are sold over the counter as dietary supplements, insurance does not cover them

GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Drug, 20242034 Figure 2: U.S

The pills are easier to store